News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
301,178 Results
Type
Article (16284)
Company Profile (301)
Press Release (284587)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (85114)
Career Advice (205)
Deals (14895)
Drug Delivery (41)
Drug Development (52102)
Employer Resources (31)
FDA (6366)
Job Trends (5459)
News (154469)
Policy (11082)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (946)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (23091)
ALS (125)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (241)
Approvals (6571)
Artificial intelligence (260)
Autoimmune disease (114)
Automation (9)
Bankruptcy (118)
Best Places to Work (4628)
BIOSECURE Act (8)
Biosimilars (100)
Biotechnology (231)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (346)
Cancer (3167)
Cardiovascular disease (249)
Career advice (183)
Career pathing (7)
CAR-T (225)
CDC (6)
Cell therapy (573)
Cervical cancer (14)
Clinical research (44939)
Collaboration (1167)
Company closure (2)
Compensation (609)
Complete response letters (39)
COVID-19 (1112)
CRISPR (86)
C-suite (566)
Cystic fibrosis (112)
Data (4409)
Denatured (15)
Depression (98)
Diabetes (277)
Diagnostics (1533)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (34021)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (53633)
Executive appointments (642)
FDA (8172)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (990)
Gene editing (182)
Generative AI (21)
Gene therapy (494)
GLP-1 (510)
Government (1181)
Grass and pollen (3)
Guidances (178)
Healthcare (6883)
HIV (26)
Huntington's disease (44)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (67)
Infectious disease (1222)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (166)
Interviews (32)
IPO (7743)
IRA (12)
Job creations (1094)
Job search strategy (153)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (246)
Leadership (9)
Legal (1823)
Liver cancer (42)
Longevity (11)
Lung cancer (423)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (385)
MASH (131)
Medical device (3013)
Medtech (3024)
Mergers & acquisitions (7786)
Metabolic disorders (750)
Multiple sclerosis (105)
NASH (13)
Neurodegenerative disease (234)
Neuropsychiatric disorders (71)
Neuroscience (1973)
Neurotech (1)
NextGen: Class of 2026 (2086)
Non-profit (900)
Now hiring (31)
Obesity (331)
Opinion (133)
Ovarian cancer (133)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (237)
Partnered (12)
Patents (303)
Patient recruitment (336)
Peanut (43)
People (28214)
Pharmaceutical (46)
Pharmacy benefit managers (6)
Phase 1 (15714)
Phase 2 (20710)
Phase 3 (13366)
Pipeline (3332)
Policy (92)
Postmarket research (1033)
Preclinical (6620)
Press Release (31)
Prostate cancer (149)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (654)
Real estate (1571)
Recruiting (12)
Regulatory (10502)
Reports (20)
Research institute (988)
Resumes & cover letters (22)
Rett syndrome (24)
RNA editing (21)
RSV (19)
Schizophrenia (123)
Series A (184)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2068)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (346)
Venture capital (70)
Weight loss (173)
Women's health (26)
Worklife (2)
Date
Today (55)
Last 7 days (329)
Last 30 days (1193)
Last 365 days (18267)
2026 (1741)
2025 (18532)
2024 (21091)
2023 (23088)
2022 (28658)
2021 (29488)
2020 (24804)
2019 (17145)
2018 (12451)
2017 (14746)
2016 (12871)
2015 (15841)
2014 (11498)
2013 (8272)
2012 (8331)
2011 (8353)
2010 (8134)
Location
Africa (168)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (6)
Asia (18790)
Australia (3211)
California (7115)
Canada (1853)
China (778)
Colorado (248)
Connecticut (252)
Delaware (238)
Europe (49572)
Florida (917)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (400)
India (38)
Indiana (163)
Iowa (9)
Japan (227)
Kansas (82)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (746)
Massachusetts (5676)
Michigan (110)
Minnesota (262)
Mississippi (3)
Missouri (33)
Montana (16)
Nebraska (6)
Nevada (34)
New Hampshire (21)
New Jersey (1691)
New Mexico (13)
New York (1802)
North Carolina (879)
North Dakota (6)
Northern California (3500)
Ohio (180)
Oklahoma (11)
Oregon (25)
Pennsylvania (1304)
Puerto Rico (9)
Rhode Island (25)
South America (240)
South Carolina (9)
Southern California (2818)
Tennessee (41)
Texas (912)
United States (23723)
Utah (96)
Virginia (164)
Washington D.C. (37)
Washington State (605)
West Virginia (1)
Wisconsin (46)
301,178 Results for "silence therapeutics plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Silence Therapeutics Announces Leadership Changes
December 16, 2025
·
3 min read
Press Releases
Silence Therapeutics to Participate in Fireside Chat at Jefferies 2025 Global Healthcare Conference
November 13, 2025
·
1 min read
Press Releases
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 7, 2025
·
7 min read
Press Releases
Silence Therapeutics to Participate in September 2025 Investor Conferences
September 3, 2025
·
1 min read
Press Releases
Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
October 24, 2025
·
6 min read
Press Releases
Scribe Therapeutics Projected to Enter the Clinic in Mid-2026 with STX-1150, a PCSK9-targeting CRISPR Epigenetic Silencing Therapy for Durable LDL-C Reduction
January 20, 2026
·
8 min read
Press Releases
Myllia Biotechnology Launches Global Virtual Cell Challenge “Echoes of Silenced Genes”
January 22, 2026
·
1 min read
Press Releases
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 7, 2025
·
8 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
Silence Therapeutics to Present at Jefferies Global Healthcare Conference
Silence Therapeutics plc today announced the Company will present at the Jefferies Global Healthcare Conference on Thursday, June 6th at 2:30 p.m. ET.
May 30, 2024
·
1 min read
1 of 30,118
Next
